JP Morgan Call 170 MRK 17.05.2024/ DE000JK2AG47 /
2024-05-07 9:09:34 AM | Chg.-0.008 | Bid10:38:13 AM | Ask10:38:13 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.010EUR | -44.44% | 0.010 Bid Size: 20,000 |
0.030 Ask Size: 20,000 |
MERCK KGAA O.N. | 170.00 EUR | 2024-05-17 | Call |
GlobeNewswire
05-06
Healthier Capital Founder and Former One Medical CEO Endorses Medeloop Amid Launch of New AI Researc...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA